EUDRAVIGILANCE at 1254026 VAERS at 710581, Vitamin D,  Llama's, OMICRON Evades All, plus DATA
Channel: VHFILM
Date: 2021-12-12

0:00 OPEN -OMICRON-neutralizing antibody titers for individuals that were vaccinated 
with mRNA vaccines  4 months or longer ago will have waned ~8-fold (5) and would now be so 
low for Omicron (~320-fold lower than recent vaccinees against WT) putting them 
outside the range of our data, and indicating very substantial reductions in VE for hospitalization, and nearly zero protection against symptomatic disease, and documented infection. ( California Department of Health, National Science Foundation )
01:22 Double Vaccination _ONLY_ Produce Zero NT against Omicron (6 months)  ( Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, 60596 Frankfurt am Main,  Germany)
09:02 Omicron doubles 3.2 - 3.6 days against those who achieved herd immunity against Delta (Department of Biosystems and Soft Matter, Institute of Fundamental Technological Research,
Polish Academy of Sciences, 02‐106 Warsaw, Poland)
09:15 Delta and omicron have evolutionary diverged into distinct phylogroups and do not share a common ancestry ( CSIR-Institute of Microbial Technology, Chandigarh, India )
11:18 Fully Vaccinated Shelter Residents hospitalized at 7x (14% vs 2%)higher rate vs Delta than Partially vaccinated  ( Sonoma County Department of Health Services, Santa Rosa, California, USA (A.R. Bukatko, M. N. Lobato, K. Reihl, S. Mase) 
14:18 Being Infected * Prior * to being vaccinated likely to confer protection against severe disease from Omicron (Africa Health Research Institute, Durban, South Africa.)
15:41 VAERS Disclaimer and data sources
17:06 Vitamin D Propholatic and Therapeutic Recommendations (Clinic of Internal Diseases, Family Medicine and Oncology, Faculty of Medicine, Vilnius University Santariškių 2, LT-08661 Vilnius, Lithuania)
23:49 What a different world it would be if we took the path of the SMALL AND NIMBLE NANO LLAMA ( ROCKEFELLER UNIVERSITY )
26:54 Recap Omicron strain spreads with the doubling time of 3.2—3.6 days in South Africa province of Gauteng that achieved herd immunity to Delta variant



Data Sources:
GISAID
HEALTHDATA GOV
CDC
OUR WORLD IN DATA
VAERS
EUDRAVIGILANCE

#omicron #antibodies #ve

Vitamin D Dosing: Basic Principles and a Brief Algorithm (2021 Update)
Bleizgys A. Vitamin D Dosing: Basic Principles and a Brief Algorithm (2021 Update). Nutrients. 2021; 13(12):4415. https://doi.org/10.3390/nu13124415

Miniature llama antibodies could help fight SARS-CoV-2 variants
eLife 2021;10:e73027 DOI: 10.7554/eLife.73027

Omicron strain spreads with the doubling time of 3.2—3.6 days in South Africa province of Gauteng that achieved herd immunity to Delta variant
Frederic Grabowski, Marek Kochańczyk, Tomasz Lipniacki
medRxiv 2021.12.08.21267494; doi: https://doi.org/10.1101/2021.12.08.21267494

Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant
Kanika Bansal, Sanjeet Kumar
bioRxiv 2021.12.06.471389; doi: https://doi.org/10.1101/2021.12.06.471389

Outbreak of COVID-19 among vaccinated and unvaccinated homeless shelter residents — Sonoma County, California, July 2021
Aleksandr Bukatko, Mark N. Lobato, Emily Mosites, Cameron Stainken, Katheryn Reihl, Mojgan Deldari, John M. Bell, Mary Kate Morris, Debra A. Wadford, Kathleen Harriman, Sundari Mase medRxiv 2021.12.07.21267204; doi: https://doi.org/10.1101/2021.12.07.21267204

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
-Yunus S. Moosa, Miles Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal
medRxiv 2021.12.08.21267417; doi: https://doi.org/10.1101/2021.12.08.21267417


Murano, K., Guo, Y., & Siomi, H. (2021). The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines. Biochemical Society Transactions. doi: doi:10.1042/BST20210859. 

Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B.1.1.529), using neutralizing antibody titers
Billy J Gardner, A. Marm Kilpatrick
medRxiv 2021.12.10.21267594; doi: https://doi.org/10.1101/2021.12.10.21267594

Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York
Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Samuel Levine, Fritz François, Eduardo Iturrate, Guiqing Wang, Meike Dittmann, Jennifer Lighter, Brian Elbel, Andrea B. Troxel, Keith S. Goldfeld, Adriana Heguy
medRxiv 2021.12.07.21267431; doi: https://doi.org/10.1101/2021.12.07.21267431